222 related articles for article (PubMed ID: 18073146)
1. Characterization of fluoroquinolone resistance mechanisms and their correlation with the degree of resistance to clinically used fluoroquinolones among Escherichia coli isolates.
Chang TM; Lu PL; Li HH; Chang CY; Chen TC; Chang LL
J Chemother; 2007 Oct; 19(5):488-94. PubMed ID: 18073146
[TBL] [Abstract][Full Text] [Related]
2. Does mutation in gyrA and/or parC or efflux pump expression play the main role in fluoroquinolone resistance in Escherichia coli urinary tract infections?: A statistical analysis study.
Shigemura K; Tanaka K; Yamamichi F; Shirakawa T; Miyake H; Fujisawa M
Int J Antimicrob Agents; 2012 Dec; 40(6):516-20. PubMed ID: 23068598
[TBL] [Abstract][Full Text] [Related]
3. Role of type II topoisomerase mutations and AcrAB efflux pump in fluoroquinolone-resistant clinical isolates of Proteus mirabilis.
Saito R; Sato K; Kumita W; Inami N; Nishiyama H; Okamura N; Moriya K; Koike K
J Antimicrob Chemother; 2006 Sep; 58(3):673-7. PubMed ID: 16870650
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms accounting for fluoroquinolone resistance in Escherichia coli clinical isolates.
Morgan-Linnell SK; Becnel Boyd L; Steffen D; Zechiedrich L
Antimicrob Agents Chemother; 2009 Jan; 53(1):235-41. PubMed ID: 18838592
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterization of clinical Streptococcus pneumoniae isolates with reduced susceptibility to fluoroquinolones emerging in Italy.
Montanari MP; Tili E; Cochetti I; Mingoia M; Manzin A; Varaldo PE
Microb Drug Resist; 2004; 10(3):209-17. PubMed ID: 15383164
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Mismatch Amplification Mutation Assay PCR and PCR-Restriction Fragment Length Polymorphism for Detection of Major Mutations in gyrA and parC of Escherichia coli Associated with Fluoroquinolone Resistance.
Jazeela K; Chakraborty G; Shetty SS; Rohit A; Karunasagar I; Vijaya Kumar D
Microb Drug Resist; 2019; 25(1):23-31. PubMed ID: 30036132
[TBL] [Abstract][Full Text] [Related]
7. Emergence of a new mutation and its accumulation in the topoisomerase IV gene confers high levels of resistance to fluoroquinolones in Escherichia coli isolates.
Moon DC; Seol SY; Gurung M; Jin JS; Choi CH; Kim J; Lee YC; Cho DT; Lee JC
Int J Antimicrob Agents; 2010 Jan; 35(1):76-9. PubMed ID: 19781915
[TBL] [Abstract][Full Text] [Related]
8. 'Supermutators' found amongst highly levofloxacin-resistant E. coli isolates: a rapid protocol for the detection of mutation sites.
Zayed AA; Essam TM; Hashem AG; El-Tayeb OM
Emerg Microbes Infect; 2015 Jan; 4(1):e4. PubMed ID: 26038761
[TBL] [Abstract][Full Text] [Related]
9. Fluoroquinolone resistance and gyrA and parC mutations of Escherichia coli isolated from chicken.
Lee YJ; Cho JK; Kim KS; Tak RB; Kim AR; Kim JW; Im SK; Kim BH
J Microbiol; 2005 Oct; 43(5):391-7. PubMed ID: 16273029
[TBL] [Abstract][Full Text] [Related]
10. Diverse phenotypic and genotypic characterization among clinical Klebsiella pneumoniae and Escherichia coli isolates carrying plasmid-mediated quinolone resistance determinants.
Yang J; Luo Y; Cui S; Wang W; Han L
Microb Drug Resist; 2011 Sep; 17(3):363-7. PubMed ID: 21563956
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of point mutations in the ygeD, gyrA and parC genes in fluoroquinolones resistant clinical isolates of Chlamydia trachomatis].
Misiurina OIu; Shipitsina EV; Finashutina IuP; Lazarev VN; Akopian TA; Savicheva AM; Govorun VM
Mol Gen Mikrobiol Virusol; 2004; (3):3-7. PubMed ID: 15354934
[TBL] [Abstract][Full Text] [Related]
12. Risk factors and mechanisms of fluoroquinolone resistance in 156 Escherichia coli strains clinically isolated from urinary tract infections.
Yasufuku T; Shigemura K; Shirakawa T; Nakano Y; Tanaka K; Arakawa S; Kinoshita S; Nishimura K; Kawabata M; Fujisawa M
Scand J Infect Dis; 2011 Feb; 43(2):83-8. PubMed ID: 20942776
[TBL] [Abstract][Full Text] [Related]
13. Contribution of Type II Topoisomerase Mutations to Fluoroquinolone Resistance in Enterococcus faecium from Japanese Clinical Setting.
Urushibara N; Suzaki K; Kawaguchiya M; Aung MS; Shinagawa M; Takahashi S; Kobayashi N
Microb Drug Resist; 2018; 24(1):1-7. PubMed ID: 28504916
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms accounting for fluoroquinolone multidrug resistance Escherichia coli isolated from companion animals.
Liu X; Boothe DM; Thungrat K; Aly S
Vet Microbiol; 2012 Dec; 161(1-2):159-68. PubMed ID: 22877517
[TBL] [Abstract][Full Text] [Related]
15. Characterization of Inhibitor-Resistant TEM β-Lactamases and Mechanisms of Fluoroquinolone Resistance in Escherichia coli Isolates.
Ríos E; López MC; Rodríguez-Avial I; Pena I; Picazo JJ
Microb Drug Resist; 2015 Oct; 21(5):512-5. PubMed ID: 25945693
[TBL] [Abstract][Full Text] [Related]
16. Contribution of a new mutation in parE to quinolone resistance in extended-spectrum-beta-lactamase-producing Escherichia coli isolates.
Sorlozano A; Gutierrez J; Jimenez A; de Dios Luna J; Martínez JL
J Clin Microbiol; 2007 Aug; 45(8):2740-2. PubMed ID: 17567787
[TBL] [Abstract][Full Text] [Related]
17. Emergence and maintenance of multidrug-resistant Escherichia coli of canine origin harbouring a blaCMY-2-IncI1/ST65 plasmid and topoisomerase mutations.
Vingopoulou EI; Siarkou VI; Batzias G; Kaltsogianni F; Sianou E; Tzavaras I; Koutinas A; Saridomichelakis MN; Sofianou D; Tzelepi E; Miriagou V
J Antimicrob Chemother; 2014 Aug; 69(8):2076-80. PubMed ID: 24722836
[TBL] [Abstract][Full Text] [Related]
18. [Fluoroquinolone resistance mutations in topoisomerase genes of Salmonella typhimurium isolates].
Guo Y; Pei X; Liu X
Wei Sheng Yan Jiu; 2004 Sep; 33(5):591-4. PubMed ID: 15612489
[TBL] [Abstract][Full Text] [Related]
19. Fluoroquinolone resistance and molecular characterization of gyrA and parC quinolone resistance-determining regions in Escherichia coli isolated from poultry.
Vanni M; Meucci V; Tognetti R; Cagnardi P; Montesissa C; Piccirillo A; Rossi AM; Di Bello D; Intorre L
Poult Sci; 2014 Apr; 93(4):856-63. PubMed ID: 24706962
[TBL] [Abstract][Full Text] [Related]
20. Fluoroquinolone resistance mechanisms in multidrug-resistant Escherichia coli isolated from extraintestinal infections in dogs.
Gibson JS; Cobbold RN; Kyaw-Tanner MT; Heisig P; Trott DJ
Vet Microbiol; 2010 Nov; 146(1-2):161-6. PubMed ID: 20471187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
